{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:15:59Z","timestamp":1791951359220,"version":"4.3.4"},"reference-count":82,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Chiasma, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Insight into the current landscape of patient-reported outcome (PRO) measures (PROM) and differences between PROs and conventional biochemical outcomes is pivotal for future implementation of PROs in research and clinical practice. Therefore, in studies among patients with acromegaly and growth hormone deficiency (GHD), we evaluated (1) used PROMs, (2) their validity, (3) quality of PRO reporting, (4) agreement between PROs and biochemical outcomes, and (5) determinants of discrepancies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Acquisition<\/jats:title>\n                  <jats:p>We searched 8 electronic databases for prospective studies describing both PROs and biochemical outcomes in acromegaly and GHD patients. Quality of PRO reporting was assessed using the International Society for Quality of Life Research (ISOQOL) criteria. Logistic regression analysis was used to evaluate determinants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Synthesis<\/jats:title>\n                  <jats:p>Ninety studies were included (acromegaly: n\u2005=\u200553; GHD: n\u2005=\u200537). Besides nonvalidated symptom lists (used in 37% of studies), 36 formal PROMs were used [predominantly Acromegaly Quality of Life Questionnaire in acromegaly (43%) and Quality of Life-Assessment of Growth Hormone Deficiency in Adults in GHD (43%)]. Reporting of PROs was poor, with a median of 37% to 47% of ISOQOL items being reported per study. Eighteen (34%) acromegaly studies and 12 (32%) GHD studies reported discrepancies between PROs and biochemical outcomes, most often improvement in biochemical outcomes without change in PROs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Prospective studies among patients with acromegaly and GHD use a multitude of PROMs, often poorly reported. Since a substantial proportion of studies report discrepancies between PROs and biochemical outcomes, PROMs are pivotal in the evaluation of disease activity. Therefore, harmonization of PROs in clinical practice and research by development of core outcome sets is an important unmet need.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab874","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T21:37:20Z","timestamp":1638826640000},"page":"1225-1238","source":"Crossref","is-referenced-by-count":27,"title":["State of the Art of Patient-reported Outcomes in Acromegaly or GH Deficiency: A Systematic Review and Meta-analysis"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0001-4408","authenticated-orcid":false,"given":"Merel","family":"van der Meulen","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2400-2070","authenticated-orcid":false,"given":"Amir H","family":"Zamanipoor Najafabadi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"},{"name":"University Neurosurgical Center Holland, Leiden University Medical Center, Haaglanden Medical Centre and Haga Teaching Hospital, Leiden and The Hague, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie H A","family":"Broersen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W","family":"Schoones","sequence":"additional","affiliation":[{"name":"Directorate of Research Policy, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-9866","authenticated-orcid":false,"given":"Alberto M","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter R","family":"van Furth","sequence":"additional","affiliation":[{"name":"University Neurosurgical Center Holland, Leiden University Medical Center, Haaglanden Medical Centre and Haga Teaching Hospital, Leiden and The Hague, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M J A","family":"Claessen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5817-3594","authenticated-orcid":false,"given":"Nienke R","family":"Biermasz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"issue":"1","key":"2022041907533126100_CIT0001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat Rev Dis Primers."},{"issue":"11","key":"2022041907533126100_CIT0002","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an Endocrine Society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022041907533126100_CIT0003","doi-asserted-by":"crossref","first-page":"dgz096","DOI":"10.1210\/clinem\/dgz096","article-title":"A consensus on the diagnosis and treatment of acromegaly comorbidities: an update","volume":"105","author":"Giustina","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022041907533126100_CIT0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"10058","key":"2022041907533126100_CIT0005","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/S0140-6736(16)30053-8","article-title":"Hypopituitarism","volume":"388","author":"Higham","year":"2016","journal-title":"Lancet."},{"issue":"26","key":"2022041907533126100_CIT0006","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1056\/NEJMra1817346","article-title":"Pathogenesis and diagnosis of growth hormone deficiency in adults","volume":"380","author":"Melmed","year":"2019","journal-title":"N Engl J Med."},{"issue":"9254","key":"2022041907533126100_CIT0007","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet."},{"issue":"1","key":"2022041907533126100_CIT0008","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-12-1088","article-title":"Long-term effects of recombinant human GH replacement in adults with GH deficiency: a systematic review","volume":"169","author":"Appelman-Dijkstra","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"2022041907533126100_CIT0009","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fendo.2017.00040","article-title":"Predictors of quality of life in acromegaly: no consensus on biochemical parameters","volume":"8","author":"Geraedts","year":"2017","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"2022041907533126100_CIT0010","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/cen.13331","article-title":"Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: results from a 5-years prospective study","volume":"86","author":"Kyriakakis","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"9","key":"2022041907533126100_CIT0011","first-page":"3184","article-title":"Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency","volume":"83","author":"Baum","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2022041907533126100_CIT0012","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"2","key":"2022041907533126100_CIT0013","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11102-017-0860-4","article-title":"How non-functioning pituitary adenomas can affect health-related quality of life: a conceptual model and literature review","volume":"21","author":"Andela","year":"2018","journal-title":"Pituitary."},{"issue":"5","key":"2022041907533126100_CIT0014","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11102-015-0636-7","article-title":"Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies","volume":"18","author":"Andela","year":"2015","journal-title":"Pituitary."},{"issue":"8","key":"2022041907533126100_CIT0015","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA."},{"issue":"6","key":"2022041907533126100_CIT0016","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11136-012-0252-1","article-title":"Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards","volume":"22","author":"Brundage","year":"2013","journal-title":"Qual Life Res."},{"issue":"2","key":"2022041907533126100_CIT0017","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(19)30790-9","article-title":"International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium","volume":"21","author":"Coens","year":"2020","journal-title":"Lancet Oncol."},{"key":"2022041907533126100_CIT0018","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"2022041907533126100_CIT0019","article-title":"Supplemental data for: State of the art of patient-reported outcomes in trials in acromegaly or growth hormone deficiency: a systematic review and meta-analysis","author":"van der Meulen"},{"key":"2022041907533126100_CIT0020","doi-asserted-by":"crossref","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","author":"McGrath","year":"2020","journal-title":"Stat Methods Med Res."},{"key":"2022041907533126100_CIT0021","volume-title":"Guideline for systematic reviews of outcome measurement instruments","year":"2020"},{"issue":"7","key":"2022041907533126100_CIT0022","first-page":"897","article-title":"Impaired health-related quality of life in meningioma patients-a systematic review","volume":"19","author":"Zamanipoor Najafabadi","year":"2017","journal-title":"Neuro Oncol."},{"issue":"1","key":"2022041907533126100_CIT0023","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11102-014-0556-y","article-title":"Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management","volume":"18","author":"Zeinalizadeh","year":"2015","journal-title":"Pituitary."},{"issue":"24","key":"2022041907533126100_CIT0024","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med."},{"issue":"3","key":"2022041907533126100_CIT0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness","volume":"13","author":"Tufanaru","year":"2015","journal-title":"Int J Evid Based Healthc."},{"key":"2022041907533126100_CIT0026","volume-title":"R: A language and environment for statistical computing","author":"R Core Team"},{"key":"2022041907533126100_CIT0027","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw."},{"issue":"4","key":"2022041907533126100_CIT0028","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health."},{"issue":"2","key":"2022041907533126100_CIT0029","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2265.2002.01597.x","article-title":"Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties","volume":"57","author":"Webb","year":"2002","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2022041907533126100_CIT0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2265.1996.704523.x","article-title":"The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency","volume":"44","author":"Wallymahmed","year":"1996","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2022041907533126100_CIT0031","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1365-2265.2003.01736.x","article-title":"Evaluation of two health status measures in adults with growth hormone deficiency","volume":"58","author":"McMillan","year":"2003","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2022041907533126100_CIT0032","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008987922774","article-title":"The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency","volume":"8","author":"McKenna","year":"1999","journal-title":"Qual Life Res."},{"issue":"3","key":"2022041907533126100_CIT0033","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/eje.0.1450255","article-title":"Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency","volume":"145","author":"Herschbach","year":"2001","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2022041907533126100_CIT0034","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00125-021-05382-x","article-title":"The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods","volume":"64","author":"Carlton","year":"2021","journal-title":"Diabetologia."},{"issue":"12","key":"2022041907533126100_CIT0035","doi-asserted-by":"crossref","first-page":"e27369","DOI":"10.1002\/pbc.27369","article-title":"Assessment of physical function in children with cancer: a systematic review","volume":"65","author":"Grimshaw","year":"2018","journal-title":"Pediatr Blood Cancer."},{"issue":"1","key":"2022041907533126100_CIT0036","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","article-title":"Quality criteria were proposed for measurement properties of health status questionnaires","volume":"60","author":"Terwee","year":"2007","journal-title":"J Clin Epidemiol."},{"issue":"3","key":"2022041907533126100_CIT0037","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11102-016-0707-4","article-title":"The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-Pituitary","volume":"19","author":"Andela","year":"2016","journal-title":"Pituitary."},{"key":"2022041907533126100_CIT0038","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1741-7015-8-24","article-title":"Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network","volume":"8","author":"Simera","year":"2010","journal-title":"BMC Med."},{"issue":"1","key":"2022041907533126100_CIT0039","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12020-020-02306-4","article-title":"Soluble klotho: a possible predictor of quality of life in acromegaly patients","volume":"69","author":"Coopmans","year":"2020","journal-title":"Endocrine."},{"issue":"1","key":"2022041907533126100_CIT0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1210\/clinem\/dgaa747","article-title":"Progression of acromegalic arthropathy in long-term controlled acromegaly patients: 9 years of longitudinal follow-up","volume":"106","author":"Pelsma","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022041907533126100_CIT0041","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s11102-017-0835-5","article-title":"Development of ACRODAT\u00ae, a new software medical device to assess disease activity in patients with acromegaly","volume":"20","author":"van der Lely","year":"2017","journal-title":"Pituitary."},{"issue":"1","key":"2022041907533126100_CIT0042","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11102-015-0681-2","article-title":"SAGIT\u00ae: clinician-reported outcome instrument for managing acromegaly in clinical practice\u2013development and results from a pilot study","volume":"19","author":"Giustina","year":"2016","journal-title":"Pituitary."},{"issue":"5","key":"2022041907533126100_CIT0043","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11102-019-00977-5","article-title":"Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT\u00ae validation study","volume":"22","author":"Giustina","year":"2019","journal-title":"Pituitary."},{"issue":"6","key":"2022041907533126100_CIT0044","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1037\/0022-3514.60.6.895","article-title":"Development and validation of a scale for measuring state self-esteem","volume":"60","author":"Heatherton","year":"1991","journal-title":"J Pers Soc Psychol."},{"issue":"11","key":"2022041907533126100_CIT0045","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1053\/joca.2002.0837","article-title":"Dimensionality and clinical importance of pain and disability in hand osteoarthritis: development of the Australian\/Canadian (AUSCAN) Osteoarthritis Hand Index","volume":"10","author":"Bellamy","year":"2002","journal-title":"Osteoarthritis Cartilage."},{"issue":"3","key":"2022041907533126100_CIT0046","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy."},{"key":"2022041907533126100_CIT0047","volume-title":"Behavioural Psychotherapy","author":"Marks","year":"1986"},{"issue":"16","key":"2022041907533126100_CIT0048","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM200004203421604","article-title":"Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant","volume":"342","author":"Trainer","year":"2000","journal-title":"N Engl J Med."},{"issue":"2","key":"2022041907533126100_CIT0049","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1207\/s15327558ijbm0302_2","article-title":"Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status","volume":"3","author":"VanderZee","year":"1996","journal-title":"Int J Behav Med."},{"issue":"12","key":"2022041907533126100_CIT0050","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol."},{"key":"2022041907533126100_CIT0051","article-title":"CPRS\u2014Development and Applications of a Psychiatric Rating Scale","author":"\u00c5sberg"},{"issue":"1","key":"2022041907533126100_CIT0052","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0447.1994.tb01480.x","article-title":"A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale","volume":"89","author":"Svanborg","year":"1994","journal-title":"Acta Psychiatr Scand."},{"issue":"4","key":"2022041907533126100_CIT0053","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005053-199304000-00006","article-title":"The defense style questionnaire","volume":"181","author":"Andrews","year":"1993","journal-title":"J Nerv Ment Dis."},{"key":"2022041907533126100_CIT0054","volume-title":"Klinische Selbstbeurteilungs-Skalen (KSb-S) aus dem M\u00fcnchener Psychiatrischen Informations-System (PSYCHIS M\u00fcnchen), Manuale. (a) Allgemeiner Teil; (b) Die Beschwerden-Liste; (c) Paranoid-Depressivit\u00e4ts-Skala, Depressivit\u00e4ts-Skala; (d) Die Befindlichkeits-Skala","author":"von Zerssen","year":"1976"},{"issue":"1","key":"2022041907533126100_CIT0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0920-1211(93)90042-6","article-title":"Measuring the impact of epilepsy: the development of a novel scale","volume":"16","author":"Jacoby","year":"1993","journal-title":"Epilepsy Res."},{"issue":"1","key":"2022041907533126100_CIT0056","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0033291700021644","article-title":"A scaled version of the General Health Questionnaire","volume":"9","author":"Goldberg","year":"1979","journal-title":"Psychol Med."},{"key":"2022041907533126100_CIT0057","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"1","key":"2022041907533126100_CIT0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bs.3830190102","article-title":"The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory","volume":"19","author":"Derogatis","year":"1974","journal-title":"Behav Sci."},{"issue":"3","key":"2022041907533126100_CIT0059","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ghir.2003.12.001","article-title":"Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption","volume":"14","author":"Svensson","year":"2004","journal-title":"Growth Horm IGF Res."},{"issue":"3","key":"2022041907533126100_CIT0060","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1528-1157.1994.tb02479.x","article-title":"Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy","volume":"35","author":"Baker","year":"1994","journal-title":"Epilepsia."},{"issue":"3","key":"2022041907533126100_CIT0061","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1017\/S003329170002225X","article-title":"A comparative psychiatric assessment of patients with chronic fatigue syndrome and muscle disease","volume":"21","author":"Wood","year":"1991","journal-title":"Psychol Med."},{"key":"2022041907533126100_CIT0062","volume-title":". The Minnesota Multiphasic Personality Inventory-2 (MMPI-2): Manual for Administration and Scoring","author":"Butcher","year":"1989"},{"key":"2022041907533126100_CIT0063","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry."},{"issue":"2","key":"2022041907533126100_CIT0064","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"2022041907533126100_CIT0065","volume-title":"Profile of Mood States (Manual)","author":"McNair","year":"1971"},{"issue":"3","key":"2022041907533126100_CIT0066","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1207\/s15327752jpa4703_14","article-title":"A shortened version of the Profile of Mood States","volume":"47","author":"Shacham","year":"1983","journal-title":"J Pers Assess."},{"key":"2022041907533126100_CIT0067","first-page":"170","article-title":"The psychological general well-being (PGWB) index.","volume-title":"Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies","author":"Dupuy","year":"1990"},{"issue":"6","key":"2022041907533126100_CIT0068","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archpsyc.1990.01810180089012","article-title":"SCAN. Schedules for clinical assessment in neuropsychiatry","volume":"47","author":"Wing","year":"1990","journal-title":"Arch Gen Psychiatry."},{"key":"2022041907533126100_CIT0069","doi-asserted-by":"crossref","DOI":"10.1515\/9781400876136","volume-title":"Society and the Adolescent Self-image","author":"Rosenberg","year":"1965"},{"issue":"9","key":"2022041907533126100_CIT0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archpsyc.1976.01770090101010","article-title":"Assessment of social adjustment by patient self-report","volume":"33","author":"Weissman","year":"1976","journal-title":"Arch Gen Psychiatry."},{"key":"2022041907533126100_CIT0071","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1192\/bjp.141.1.68","article-title":"Evaluation of a modified self-report measure of social adjustment","volume":"141","author":"Cooper","year":"1982","journal-title":"Br J Psychiatry."},{"key":"2022041907533126100_CIT0072","volume-title":"Manual for the State-trait Anxiety Inventory","author":"Spielberger","year":"1983"},{"issue":"1","key":"2022041907533126100_CIT0073","first-page":"13","article-title":"SCL-90: an outpatient psychiatric rating scale\u2013preliminary report","volume":"9","author":"Derogatis","year":"1973","journal-title":"Psychopharmacol Bull."},{"issue":"6","key":"2022041907533126100_CIT0074","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep."},{"issue":"6","key":"2022041907533126100_CIT0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand."},{"issue":"7","key":"2022041907533126100_CIT0076","first-page":"268","article-title":"A symptom questionnaire","volume":"48","author":"Kellner","year":"1987","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"2022041907533126100_CIT0077","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000506110","article-title":"Kellner\u2019s symptom questionnaire, a highly sensitive patient-reported outcome measure: systematic review of clinimetric properties","volume":"89","author":"Benasi","year":"2020","journal-title":"Psychother Psychosom."},{"issue":"3","key":"2022041907533126100_CIT0078","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue","volume":"39","author":"Smets","year":"1995","journal-title":"J Psychosom Res."},{"issue":"4","key":"2022041907533126100_CIT0079","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jech.34.4.281","article-title":"A quantitative approach to perceived health status: a validation study","volume":"34","author":"Hunt","year":"1980","journal-title":"J Epidemiol Community Health."},{"issue":"6","key":"2022041907533126100_CIT0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form health Survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care."},{"issue":"16","key":"2022041907533126100_CIT0081","article-title":"Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study","volume":"16","author":"Bronstein","year":"2016","journal-title":"BMC Endocr Disord."},{"issue":"1","key":"2022041907533126100_CIT0082","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.1995.tb02601.x","article-title":"Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults","volume":"42","author":"Beshyah","year":"1995","journal-title":"Clin Endocrinol (Oxf)."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab874\/42092894\/dgab874.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/5\/1225\/43386521\/dgab874.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/5\/1225\/43386521\/dgab874.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T08:00:23Z","timestamp":1650355223000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/5\/1225\/6454312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":82,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,12,6]]},"published-print":{"date-parts":[[2022,4,19]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab874","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2021,12,6]]}}}